Tali Cukierman-Yaffe

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. pmc LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact
    Elie A Akl
    Department of Medicine, State University of New York at Buffalo, Buffalo, USA
    Trials 10:40. 2009
  2. ncbi Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies
    T Cukierman
    Division of Endocrinology and Metabolism and Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada
    Diabetologia 48:2460-9. 2005
  3. ncbi The relationship between dysglycemia and cognitive dysfunction
    Tali Cukierman-Yaffee
    Gertner Institute for Epidemiology and Health Policy Research, Endocrinology Institute, Sheba Medical Center, Epidemiology Department, Sackler School of Medicine, Tel Aviv University, Israel
    Curr Opin Investig Drugs 10:70-4. 2009
  4. doi Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme
    Tali Cukierman-Yaffe
    Population Health Research Institute, McMaster University, Canada
    Diabetes Res Clin Pract 83:387-93. 2009
  5. pmc Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial
    Tali Cukierman-Yaffe
    Gertner Institute for Epidemiology and Health Policy Research, Endocrinology Institute Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Diabetes Care 32:221-6. 2009
  6. doi Key elements for successful intensive insulin pump therapy in individuals with type 1 diabetes
    Tali Cukierman-Yaffe
    Endocrinology Institute, Sheba Medical Center, Israel
    Diabetes Res Clin Pract 92:69-73. 2011
  7. ncbi Dysglycemia and Cognitive Dysfunction and Ill Health in People With High CV Risk: Results From the ONTARGET/TRANSCEND Studies
    Tali Cukierman-Yaffe
    Endocrinology Institute T C Y, Gertner Institute, Sheba Medical Center, Tel Hashomer 52621, Israel Department of Epidemiology T C Y, Tel Aviv University, Tel Aviv 69978, Israel Population Health Research Institute T C Y, K T, P G, H C G, S Y, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada L8Z 3N5 Royal Prince Alfred Hospital C A, Camperdown 2050, Australia The George Institute for Global Health C A, Oxford OX1 3BD, United Kingdom and University of Sydney C A, Sydney 2006, Australia
    J Clin Endocrinol Metab 100:2682-9. 2015

Collaborators

Detail Information

Publications7

  1. pmc LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact
    Elie A Akl
    Department of Medicine, State University of New York at Buffalo, Buffalo, USA
    Trials 10:40. 2009
    ..The secondary objectives are to describe, for published RCTs, (1) the reporting of loss to follow-up information, (2) the analytic methods used for handling loss to follow-up information, and (3) the extent of reported loss to follow-up...
  2. ncbi Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies
    T Cukierman
    Division of Endocrinology and Metabolism and Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada
    Diabetologia 48:2460-9. 2005
    ..We systematically reviewed and summarised prospective data relating diabetes status to changes in cognitive function over time...
  3. ncbi The relationship between dysglycemia and cognitive dysfunction
    Tali Cukierman-Yaffee
    Gertner Institute for Epidemiology and Health Policy Research, Endocrinology Institute, Sheba Medical Center, Epidemiology Department, Sackler School of Medicine, Tel Aviv University, Israel
    Curr Opin Investig Drugs 10:70-4. 2009
    ..The aim of this review is to describe the importance of this relationship, the evidence supporting it and possible explanations, and the possible role of insulin and insulin resistance in this relationship...
  4. doi Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme
    Tali Cukierman-Yaffe
    Population Health Research Institute, McMaster University, Canada
    Diabetes Res Clin Pract 83:387-93. 2009
    ..To assess the cross-sectional associations of the measures of glycemia and cognitive function in subjects at high cardiovascular risk...
  5. pmc Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial
    Tali Cukierman-Yaffe
    Gertner Institute for Epidemiology and Health Policy Research, Endocrinology Institute Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
    Diabetes Care 32:221-6. 2009
    ..This was explored using baseline cognitive measures collected in the ongoing Memory in Diabetes (MIND) substudy of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial...
  6. doi Key elements for successful intensive insulin pump therapy in individuals with type 1 diabetes
    Tali Cukierman-Yaffe
    Endocrinology Institute, Sheba Medical Center, Israel
    Diabetes Res Clin Pract 92:69-73. 2011
    ..Thus, the aim of this analysis was to assess which features and parameters of insulin pump use are associated with better glucose control...
  7. ncbi Dysglycemia and Cognitive Dysfunction and Ill Health in People With High CV Risk: Results From the ONTARGET/TRANSCEND Studies
    Tali Cukierman-Yaffe
    Endocrinology Institute T C Y, Gertner Institute, Sheba Medical Center, Tel Hashomer 52621, Israel Department of Epidemiology T C Y, Tel Aviv University, Tel Aviv 69978, Israel Population Health Research Institute T C Y, K T, P G, H C G, S Y, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada L8Z 3N5 Royal Prince Alfred Hospital C A, Camperdown 2050, Australia The George Institute for Global Health C A, Oxford OX1 3BD, United Kingdom and University of Sydney C A, Sydney 2006, Australia
    J Clin Endocrinol Metab 100:2682-9. 2015
    ..Avoidance of death, disability, dementia, and cognitive dysfunction (DDCD) are high priorities for people in aging societies. Evidence is mounting that these conditions are associated with impaired glycemic control...